NCT01065077 - BAY58-2667 Dose Finding Trial Investigating Fixed Doses in Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

February 28, 2011

Conditions

Acute Heart Failure

Interventions

DRUG

Cinaciguat (BAY58-2667)

Infusion of 150 µg/h during 48h

DRUG

Cinaciguat (BAY58-2667)

Infusion of 100 µg/h during 48h

DRUG

Cinaciguat (BAY58-2667)

Infusion of 50 µg/h during 48h

DRUG

Placebo

Infusion of placebo during 48h

Trial Locations (59)

1000

Ljubljana

1090

Vienna

3000

Celje

4010

Linz

4204

Golnik

6900

Lugano

8091

Zurich

10000

Zagreb

10126

Torino

10400

Bangkok

11000

Belgrade

17475

Greifswald

18000

Niš

19102

Philadelphia

19107

Philadelphia

21204

Kamenitz

22020

San Fermo della Battaglia

25100

Brescia

27157

Winston-Salem

31905

Tiberias

34362

Haifa

44100

Ferrara

44106

Cleveland

45014

Fairfield

46100

Mantova

50924

Cologne

66424

Homburg

90220

Oulu

91120

Jerusalem

99089

Erfurt

109263

Moscow

115093

Moscow

119881

Moscow

400001

Cluj-Napoca

660022

Krasnoyarsk

07450

Ridgewood

00029

Helsinki

07740

Jena

460-0001

Nagoya

737-0023

Kure

311-3193

Higashiibaraki

216-8511

Kawasaki

856-8562

Ōmura

543-0035

Osaka

113-8603

Bunkyo-ku

142-8666

Shinagawa

80-211

Gdansk

91-347

Lodz

02-507

Warsaw

04-628

Warsaw

50-981

Wroclaw

41-800

Zabrze

59-900

Zgorzelec

022328

Bucharest

984 39

Lučenec

036 59

Martin

413 45

Gothenburg

751 85

Uppsala